Skip to search formSkip to main contentSkip to account menu

Sandostatin

Known as: Sandostatine 
National Institutes of Health

Related topics

Related topics

17 relations

Narrower (6)

3-Tyr-octreotideCPTA-D-Phe(1)-octreotideRC 121SDZ 413

Broader (7)

AntidiarrhealsAntineoplastic Agents, HormonalGastrointestinal AgentsOctreotide
Octreotide 10 MG Injection [Sandostatin]Octreotide 30 MG Injection [Sandostatin]SMS 201-995lanreotide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Update on meningiomas.
Although meningiomas are the most common tumor in the central nervous system, their incidence, epidemiology, and clinical… 
Highly Cited
2003
Highly Cited
2003
Sandostatin LAR (long‐acting octreotide acetate) for malignant carcinoid syndrome: a 3‐year experience
Background : Somatostatin analogues are the best therapy for controlling the symptoms of malignant carcinoid syndrome. Octreotide… 
Highly Cited
2002
Highly Cited
2002
The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.
BACKGROUND/AIMS The overexpression of somatostatin receptors in the liver of some patients with hepatocellular carcinoma is well… 
Highly Cited
2001
Highly Cited
2001
Occurrence of ventricular late potentials in patients with active acromegaly
OBJECTIVE Patients with acromegaly have an increased risk of ventricular dysrhythmias and sudden death. Late potentials in a… 
Highly Cited
1997
Highly Cited
1997
Multiconformational NMR analysis of sandostatin (octreotide): equilibrium between beta-sheet and partially helical structures.
This paper reports a detailed conformational analysis by 1H NMR (DMSO-d6, 300 K) and molecular modeling of the octapeptide D-Phe1… 
Highly Cited
1993
Highly Cited
1993
Effects of neuropeptides on neutrophil migration through noncellular and endothelial barriers.
Highly Cited
1993
Highly Cited
1993
Gastroenteropancreatic endocrine tumours: effect of Sandostatin on tumour growth. The German Sandostatin Study Group.
One hundred and fifteen gastroenteropancreatic (GEP) patients with malignant endocrine tumours entered a prospective multicentre… 
Review
1993
Review
1993
Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.
Somatostatin is widely distributed throughout the human gastrointestinal system. There it is found in neurons and fibers of both… 
Highly Cited
1990
Highly Cited
1990
Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.
Somatostatin analogues can suppress the secretion of some gastrointestinal hormones and growth factors involved in the growth… 
Highly Cited
1987
Highly Cited
1987
Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.
The effect of the long-acting somatostatin analogue Sandostatin (SMS 201-995) on intestinal absorption and propagation (mouth-to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)